Cornell faculty contribute to Astro2020 decadal survey

The newly released “Pathways to Discovery in Astronomy and Astrophysics for the 2020s,” identifies scientific priorities, opportunities and funding recommendations for the next 10 years of astronomy and astrophysics.

Can't find your keys? You need a chickadee brain

For the first time, researchers have shown that there is a genetic component underlying the amazing spatial memories of mountain chickadees, which hide thousands of food items every fall and rely on these hidden stores to get through harsh winters.

‘Miracle dog’ goes into fifth remission from lymphoma

Indy, a puggle-Boston terrier mix, has been treated with different chemotherapies five times and gone into remission each time at the College for Veterinary Medicine.

NSF awards $1.3M to CCAT-prime telescope project

The CCAT-prime telescope project – being developed by an international consortium of universities, led by Cornell – has been awarded $1.3 million by the National Science Foundation.

Study provides keys to managing influx of EV batteries

A new Cornell-led study identifies several keys to sustainably managing the influx, with an emphasis on battery chemistry, second-life applications and recycling.

Oral drug enhances radiation therapy for cancer

Treatment with the amino acid arginine enhanced the effectiveness of radiation therapy in cancer patients with brain metastases in a clinical trial from investigators at Weill Cornell Medicine and Angel H. Roffo Cancer Institute.

$1.8M gift supports the Emerging Markets Institute

A $1.8 million gift from Gail and Roberto Cañizares ’71, MBA ’74, will provide substantial support to the Emerging Markets Institute at the Cornell SC Johnson College of Business.

Enzyme research unlocks gateway for new medicines

The new findings published in Science capture never-before-recorded stages of a molecular construction process, with implications for future pharmaceutical development.

Estrogen exposure may protect women from Alzheimer’s

A new study suggests that greater cumulative exposure to estrogen in life may counter the decline in brain-matter volume that occurs with menopause, in key brain regions affected in Alzheimer's disease.